Story thread · 4 reports / 4 sources

Biodiversity AI Raises $140M to Deliver Gene Therapy Without Factories

techtimes.com · 9hShare

AI-designed gene therapy company Basecamp Research closed a $140 million Series C to train EDEN biological AI models on genetic data from more than 1 million newly sequenced species. The company's in vivo cell therapy approach targets a $400,000-plus manufacturing bottleneck in cancer treatment, though all six pipeline programs remain in early preclinical stages.

First report: CAR T-Cell Therapy: Durable Responses Reshape Cancer Care — medscape.com, 2d